Literature DB >> 14507633

Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.

Bernard Burke1, Athina Giannoudis, Kevin P Corke, Dalvir Gill, Michael Wells, Loems Ziegler-Heitbrock, Claire E Lewis.   

Abstract

Macrophages accumulate in ischemic areas of such pathological tissues as solid tumors, atherosclerotic plaques and arthritic joints. Studies have suggested that hypoxia alters the phenotype of macrophages in a way that promotes these lesions. However, the genes up-regulated by macrophages in such hypoxic tissues are poorly characterized. Here, we have used cDNA array hybridization to investigate the effects of hypoxia on the mRNAs of 1185 genes in primary human monocyte-derived macrophages. As shown previously in other cell types, mRNA levels for vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT-1) were up-regulated by hypoxia. However, the mRNAs of other genes were also up-regulated including matrix metalloproteinase-7 (MMP-7), neuromedin B receptor, and the DNA-binding protein inhibitor, Id2. The promoters of GLUT-1 and MMP-7 confer hypoxic inducibility on a reporter gene in RAW 264.7 macrophages, indicating that the hypoxic up-regulation of these mRNAs may occur, at least in part, at the transcriptional level. GLUT-1 and MMP-7 mRNA were also shown to be up-regulated in hypoxic macrophages in vitro by real-time RT-PCR, and these proteins were elevated in hypoxic macrophages in vitro and in hypoxic areas of human breast tumors. The hypoxia up-regulated genes identified could be important for the survival and functioning of macrophages in hypoxic diseased tissues, and their promoters could prove useful in macrophage-delivered gene therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14507633      PMCID: PMC1868302          DOI: 10.1016/S0002-9440(10)63483-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

Review 1.  Hypoxia and inflammatory synovitis: observations and speculation.

Authors:  C R Stevens; R B Williams; A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

2.  The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumors.

Authors:  H C Crawford; B Fingleton; M D Gustavson; N Kurpios; R A Wagenaar; J A Hassell; L M Matrisian
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 3.  beta-Thymosins, small acidic peptides with multiple functions.

Authors:  T Huff; C S Müller; A M Otto; R Netzker; E Hannappel
Journal:  Int J Biochem Cell Biol       Date:  2001-03       Impact factor: 5.085

4.  Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells.

Authors:  A Ouiddir; C Planès; I Fernandes; A VanHesse; C Clerici
Journal:  Am J Respir Cell Mol Biol       Date:  1999-12       Impact factor: 6.914

5.  Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide.

Authors:  H Kimura; A Weisz; T Ogura; Y Hitomi; Y Kurashima; K Hashimoto; F D'Acquisto; M Makuuchi; H Esumi
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

Review 6.  HIF-1: using two hands to flip the angiogenic switch.

Authors:  G L Semenza
Journal:  Cancer Metastasis Rev       Date:  2000       Impact factor: 9.264

7.  Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

Authors:  N Mitsiades; W H Yu; V Poulaki; M Tsokos; I Stamenkovic
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

8.  Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation--a potential mechanism.

Authors:  M J Grimshaw; F R Balkwill
Journal:  Eur J Immunol       Date:  2001-02       Impact factor: 5.532

9.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

Authors:  H Yamamoto; F Itoh; S Iku; Y Adachi; H Fukushima; S Sasaki; M Mukaiya; K Hirata; K Imai
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

10.  Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia.

Authors:  C Chen; N Pore; A Behrooz; F Ismail-Beigi; A Maity
Journal:  J Biol Chem       Date:  2000-12-18       Impact factor: 5.157

View more
  91 in total

1.  Cell proliferation and oxidative stress pathways are modified in fibroblasts from Sturge-Weber syndrome patients.

Authors:  Shilpa D Kadam; Marjan Gucek; Robert N Cole; Paul A Watkins; Anne M Comi
Journal:  Arch Dermatol Res       Date:  2012-03-10       Impact factor: 3.017

Review 2.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 3.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

4.  Cleavage of myelin associated glycoprotein by matrix metalloproteinases.

Authors:  Elizabeth Milward; Kee Jun Kim; Arek Szklarczyk; Thien Nguyen; Giorgia Melli; Mamatha Nayak; Deepa Deshpande; Chantel Fitzsimmons; Ahmet Hoke; Douglas Kerr; John W Griffin; Peter A Calabresi; Katherine Conant
Journal:  J Neuroimmunol       Date:  2007-12-11       Impact factor: 3.478

Review 5.  Inflammation: therapeutic targets for diabetic neuropathy.

Authors:  Jiyin Zhou; Shiwen Zhou
Journal:  Mol Neurobiol       Date:  2013-08-30       Impact factor: 5.590

Review 6.  Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaB.

Authors:  Simon Hallam; Monica Escorcio-Correia; Robin Soper; Anne Schultheiss; Thorsten Hagemann
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

7.  Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer.

Authors:  Jessica E S Shay; Hongxia Z Imtiyaz; Sharanya Sivanand; Amy C Durham; Nicolas Skuli; Sarah Hsu; Vera Mucaj; T S Karin Eisinger-Mathason; Bryan L Krock; Dionysios N Giannoukos; M Celeste Simon
Journal:  Carcinogenesis       Date:  2014-01-09       Impact factor: 4.944

Review 8.  Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

Authors:  Thorsten Hagemann; Subhra K Biswas; Toby Lawrence; Antonio Sica; Claire E Lewis
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

Review 9.  Changes in cellular mechanical properties during onset or progression of colorectal cancer.

Authors:  Gabriele Ciasca; Massimiliano Papi; Eleonora Minelli; Valentina Palmieri; Marco De Spirito
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

10.  Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.

Authors:  Stilla Frede; Christian Stockmann; Patricia Freitag; Joachim Fandrey
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.